Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19


      Subphenotypes have been identified in patients with sepsis and ARDS and are associated with different outcomes and responses to therapies.

      Research Question

      Can unique subphenotypes be identified among critically ill patients with COVID-19?

      Study Design and Methods

      Using data from a multicenter cohort study that enrolled critically ill patients with COVID-19 from 67 hospitals across the United States, we randomly divided centers into discovery and replication cohorts. We used latent class analysis independently in each cohort to identify subphenotypes based on clinical and laboratory variables. We then analyzed the associations of subphenotypes with 28-day mortality.


      Latent class analysis identified four subphenotypes (SP) with consistent characteristics across the discovery (45 centers; n = 2,188) and replication (22 centers; n = 1,112) cohorts. SP1 was characterized by shock, acidemia, and multiorgan dysfunction, including acute kidney injury treated with renal replacement therapy. SP2 was characterized by high C-reactive protein, early need for mechanical ventilation, and the highest rate of ARDS. SP3 showed the highest burden of chronic diseases, whereas SP4 demonstrated limited chronic disease burden and mild physiologic abnormalities. Twenty-eight-day mortality in the discovery cohort ranged from 20.6% (SP4) to 52.9% (SP1). Mortality across subphenotypes remained different after adjustment for demographics, comorbidities, organ dysfunction and illness severity, regional and hospital factors. Compared with SP4, the relative risks were as follows: SP1, 1.67 (95% CI, 1.36-2.03); SP2, 1.39 (95% CI, 1.17-1.65); and SP3, 1.39 (95% CI, 1.15-1.67). Findings were similar in the replication cohort.


      We identified four subphenotypes of COVID-19 critical illness with distinct patterns of clinical and laboratory characteristics, comorbidity burden, and mortality.

      Key Words


      AKI (acute kidney injury), SP1, SP2, SP3, SP4 (subphenotype 1, subphenotype 2, subphenotype 3, subphenotype 4), STOP-COVID (Study of Treatment and Outcomes in Critically Ill Patients With COVID-19)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wiersinga W.J.
        • Rhodes A.
        • Cheng A.C.
        • Peacock S.J.
        • Prescott H.C.
        Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review.
        JAMA. 2020; 324: 782-793
        • Gattinoni L.
        • Chiumello D.
        • Caironi P.
        • et al.
        COVID-19 pneumonia: different respiratory treatments for different phenotypes?.
        Intensive Care Med. 2020; 46: 1099-1102
        • Li X.
        • Ma X.
        Acute respiratory failure in COVID-19: is it “typical” ARDS?.
        Crit Care. 2020; 24: 198
        • Marini J.J.
        • Gattinoni L.
        Management of COVID-19 respiratory distress.
        JAMA. 2020; 323: 2329-2330
        • Spyropoulos A.C.
        • Weitz J.I.
        Hospitalized COVID-19 patients and venous thromboembolism: a perfect storm.
        Circulation. 2020; 142: 129-132
        • Cardone M.
        • Yano M.
        • Rosenberg A.S.
        • Puig M.
        Lessons learned to date on COVID-19 hyperinflammatory syndrome: considerations for interventions to mitigate SARS-CoV-2 viral infection and detrimental hyperinflammation.
        Front Immunol. 2020; 11: 1131
        • Reddy K.
        • Sinha P.
        • O’Kane C.M.
        • Gordon A.C.
        • Calfee C.S.
        • McAuley D.F.
        Subphenotypes in critical care: translation into clinical practice.
        Lancet Respir Med. 2020; 8: 631-643
        • Seymour C.W.
        • Kennedy J.N.
        • Wang S.
        • et al.
        Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.
        JAMA. 2019; 321: 2003-2017
        • Calfee C.S.
        • Delucchi K.
        • Parsons P.E.
        • et al.
        Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
        Lancet Respir Med. 2014; 2: 611-620
        • Bhatraju P.K.
        • Zelnick L.R.
        • Herting J.
        • et al.
        Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy.
        Am J Respir Crit Care Med. 2019; 199: 863-872
        • Hagenaars J.A.
        • McCutcheon A.L.
        Applied Latent Class Analysis.
        Cambridge University Press, 2002
        • Reilly J.P.
        • Bellamy S.
        • Shashaty M.G.
        • et al.
        Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma.
        Ann Am Thorac Soc. 2014; 11: 728-736
        • Gupta S.
        • Hayek S.S.
        • Wang W.
        • et al.
        Factors associated with death in critically ill patients with coronavirus disease 2019 in the US.
        JAMA Intern Med. 2020; 180: 1436-1447
        • Nylund K.L.
        • Asparouhov T.
        • Muthén B.O.
        Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study.
        Struct Equ Modeling. 2007; 14: 535-569
        • Lo Y.
        • Mendell N.R.
        • Rubin D.B.
        Testing the number of components in a normal mixture.
        Biometrika. 2001; 88: 767-778
        • Harhay M.O.
        • Porcher R.
        • Cantu E.
        • et al.
        An alternative approach for the analysis of time-to-event and survival outcomes in pulmonary medicine.
        Am J Respir Crit Care Med. 2018; 198: 684-687
        • Zou G.
        A modified Poisson regression approach to prospective studies with binary data.
        Am J Epidemiol. 2004; 159: 702-706
        • Thompson B.T.
        • Chambers R.C.
        • Liu K.D.
        Acute respiratory distress syndrome.
        N Engl J Med. 2017; 377: 562-572
        • Hoste E.A.J.
        • Kellum J.A.
        • Selby N.M.
        • et al.
        Global epidemiology and outcomes of acute kidney injury.
        Nat Rev Nephrol. 2018; 14: 607-625
        • Wolberg A.S.
        • Rosendaal F.R.
        • Weitz J.I.
        • et al.
        Venous thrombosis.
        Nat Rev Dis Primers. 2015; 1: 15006
        • Rodriguez-Acelas A.L.
        • de Abreu Almeida M.
        • Engelman B.
        • Canon-Montanez W.
        Risk factors for health care-associated infection in hospitalized adults: systematic review and meta-analysis.
        Am J Infect Control. 2017; 45: e149-e156
        • Bui A.L.
        • Horwich T.B.
        • Fonarow G.C.
        Epidemiology and risk profile of heart failure.
        Nat Rev Cardiol. 2011; 8: 30-41
        • Hsu J.Y.
        • Roy J.A.
        • Xie D.
        • et al.
        Statistical methods for cohort studies of CKD: survival analysis in the setting of competing risks.
        Clin J Am Soc Nephrol. 2017; 12: 1181-1189
        • Petersen E.
        • Koopmans M.
        • Go U.
        • et al.
        Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
        Lancet Infect Dis. 2020; 20: e238-e244
        • Sinha P.
        • Delucchi K.L.
        • McAuley D.F.
        • O’Kane C.M.
        • Matthay M.A.
        • Calfee C.S.
        Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.
        Lancet Respir Med. 2020; 8: 247-257
        • Price-Haywood E.G.
        • Burton J.
        • Fort D.
        • Seoane L.
        Hospitalization and mortality among Black patients and white patients with Covid-19.
        N Engl J Med. 2020; 382: 2534-2543
        • United States Census Bureau
        2018 Population estimates by age, sex, race and Hispanic origin. 2019. United States Census Bureau website.
        • Centers for Disease Control and Prevention
        Racial and ethnic disparities in heart disease. 2019. Centers for Disease Control and Prevention website.
        • Scicluna B.P.
        • van Vught L.A.
        • Zwinderman A.H.
        • et al.
        Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study.
        Lancet Respir Med. 2017; 5: 816-826
        • Davenport E.E.
        • Burnham K.L.
        • Radhakrishnan J.
        • et al.
        Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study.
        Lancet Respir Med. 2016; 4: 259-271
        • Calfee C.S.
        • Delucchi K.L.
        • Sinha P.
        • et al.
        Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
        Lancet Respir Med. 2018; 6: 691-698
        • Famous K.R.
        • Delucchi K.
        • Ware L.B.
        • et al.
        Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy.
        Am J Respir Crit Care Med. 2017; 195: 331-338
        • Sinha P.
        • Calfee C.S.
        • Cherian S.
        • et al.
        Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
        Lancet Respir Med. 2020; 8: 1209-1218
        • Mathew D.
        • Giles J.R.
        • Baxter A.E.
        • et al.
        Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
        Science. 2020; 369: eabc8511
        • Horby P.
        • Lim W.S.
        • et al.
        • RECOVERY Collaborative Group
        Dexamethasone in hospitalized patients with Covid-19.
        N Engl J Med. 2020; 384: 693-704